Browse through our recent news and keep up to date with the latest on what’s been happening at Neuroclin Glasgow.
Work Experience at Glasgow Memory Clinic
Diary – Areej At our clinic, we are always eager to provide opportunities for young, ambitious individuals who are interested in pursuing a career in research. This is why we are pleased to offer a short period of work experience for those who are looking to get a glimpse into the world of healthcare and … Continued
New Alzheimer’s drug slows disease by a third.
Further highly encouraging results announced today regarding Alzheimer’s vaccine research. The results for the experimental vaccine Donanemab being developed by Lilly show important evidence of amyloid reduction associated with reduced functional decline. Dr Fraser Inglis, Founder and Director of Research at Glasgow Memory Clinic, a Neuroclin centre commented “The results provide further strong support that … Continued
A Marathon Effort to Raise Funds for the Alzheimer’s Society
This year, our very own Monica Crone is taking on the challenge of a lifetime by running the Virgin Money London Marathon to raise funds for the Alzheimer’s Society. Monica is our clinic Research Manager, and she has been training hard for the past few months to make sure she’s ready for the big day. … Continued
Are you living with Parkinson’s disease?
Are you living with Parkinson’s? As reportedly the world’s fastest-growing neurological condition, Parkinson’s disease has been rising exponentially. In the UK alone, there are around 145,000 individuals living with Parkinson’s- and that number is still climbing. In Scotland, 30 people are diagnosed with Parkinson’s every week An estimated 12,400 people have a diagnosis of Parkinson’s … Continued
2022 Recap and looking AHEAD to 2023
2022 has been the busiest year yet for the clinic, with a record number of volunteers applying to take part in our Alzheimer’s and Parkinson’s current studies – making it one of the most successful years ever. We’ve welcomed volunteers from all walks of life; some as young as 40 years old with the introduction … Continued
Alzheimer’s drug Lecanemab hailed as momentous breakthrough
Trending news, read the latest BBC article here: The first drug to slow the destruction of the brain in Alzheimer’s has been heralded as momentous. Earlier today, Dr Fraser Inglis, Founder and Director Research at Glasgow Memory Clinic, a NEUROCLIN centre commented… “Very positive results announced last night from the CTAD 2022 Congress in San Francisco, … Continued
Alzheimer’s Disease Medications and Research Studies
According to the Alzheimer’s Society there are approximately 900,000 people with dementia in the UK. This figure is set to rise and this year alone 209,600 people will develop dementia, that’s one every three minutes. For those diagnosed with Alzheimer’s, many will then be prescribed specific medication as part of their treatment for the disease. … Continued
Which study is right for me?
How do I know which study is right for me? With so many clinical research studies underway, it can be difficult to know which one is right for you. As one of the leading centres in Europe developing new treatments for Memory Impairment, Alzheimer’s disease, Dementia and more recently Parkinson’s disease, we are the only … Continued
Jeremy Paxman Gets Parkinson’s Diagnosis After Doctor Saw Him on TV
In a recent interview, British journalist and broadcaster Jeremy Paxman revealed that he had been diagnosed with Parkinson’s disease after a doctor noticed him on TV. Parkinson’s disease is a condition in which parts of the brain become progressively damaged over many years. The three main symptoms of the condition are involuntary shaking of particular … Continued
A Volunteer’s Guide: Your first visit to our clinic – what to expect
Your first visit to our clinic – what to expect At our clinic, we welcome new volunteers for clinical studies every day. We understand that applying to take part in a clinical study can be a big decision for many. We wanted to put together a guide to explain the process from start to finish, … Continued